Edwards Lifesciences Corporation
Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 13.6%, EPS fell 26.3%, free cash flow grew 142.8% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow EW
Edwards Lifesciences Corporation (EW) Current ratio
Edwards Lifesciences Corporation's current ratio at the end of the quarter to 30 June 2026 was 4.5×, up 0.8× from fiscal 2025 (3.7×). Over the past ten years it has ranged from 1.8× (fiscal 2017) to 4.3× (fiscal 2015); the current reading is higher than 73% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 3.0×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 3.7× | (11.02%) |
| FY2024 | 4.2× | 23.69% |
| FY2023 | 3.4× | 11.49% |
| FY2022 | 3.0× | (1.73%) |
| FY2021 | 3.1× | (10.89%) |
| FY2020 | 3.5× | 4.57% |
| FY2019 | 3.3× | 26.75% |
| FY2018 | 2.6× | 45.32% |
| FY2017 | 1.8× | (57.32%) |
| FY2016 | 4.2× | (2.18%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 4.5× | 2.29% |
| Mar 2026 | 4.4× | 18.98% |
| Dec 2025 | 3.7× | (7.21%) |
| Sep 2025 | 4.0× | (14.48%) |
| 42 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| EW Edwards Lifesciences Corporation | 4.5× |
| SYK Stryker Corporation compare | 2.2× |
| MDT Medtronic PLC compare | 2.1× |
| STE STERIS plc compare | 1.9× |
| DXCM DexCom, Inc. compare | 1.7× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 1.7× |
| GEHC GE HealthCare Technologies Inc. compare | 1.3× |
| PHG Koninklijke Philips N.V. compare | 1.3× |
| BSX Boston Scientific Corporation compare | 1.2× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 3.0× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on EW
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement